European Biotech Charts Alternative Path in Regenerative Medicine
European Biotech Charts Alternative Path in Regenerative Medicine Europe’s biotechnology sector is developing distinctive approaches to regenerative medicine, emphasising accessibility and sustainable economics alongside commercial objectives. This represents a marked contrast to Silicon Valley’s venture capital-driven model that prioritizes rapid growth and exit strategies. Dutch incorporation provides strategic advantages for biotechnology companies. The Netherlands offers…